Skip to content
Loading…
AbbVie Inc. is seeking to raise at least $8 billion from an investment-grade bond offering to fund a portion of its acquisition of Apogee Therapeutics Inc.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.